The regulatory landscape for GP fundraising compliance in Europe has changed more in the last four years than in the preceding two decades. Three frameworks — MiFID II, AIFMD II, and the Cross-Border Distribution Framework (CBDF) — now intersect in ways that create real legal exposure for fund managers who haven't updated their engagement protocols. Non-compliance is no longer a technical violation. It's a deal-killer that can prevent a close from completing.
This article breaks down the key compliance obligations European GPs face when engaging institutional LPs, and what a compliance-aware fundraising process looks like in practice.
The regulatory stack every European GP must know
| Framework | What it governs | GP impact |
|---|---|---|
| AIFMD II | Marketing of AIFs to professional investors in the EU | Requires passport or national private placement regime; imposes disclosure, reporting, and depositary requirements |
| MiFID II | Investment advice and financial instruments | Governs how fund interests can be promoted; requires suitability assessment when providing advice |
| CBDF (Regulation EU 2019/1156) | Cross-border marketing of collective investment schemes | Standardizes national rules on pre-marketing; introduces notification requirements; restricts what constitutes "pre-marketing" |
| PRIIPs | Packaged retail and insurance-based investment products | Key Information Document (KID) requirements for non-institutional investors; scope creep into semi-professional categories |
Pre-marketing under CBDF: where GPs most often go wrong
The CBDF's definition of "pre-marketing" is narrower than most GPs assume. Under Article 30a of AIFMD (as amended by CBDF), pre-marketing is defined as information or communication — direct or indirect — about investment strategies or ideas, provided to potential professional investors in the EU, before formal registration for marketing.
The practical implication: many activities GPs consider "exploratory outreach" are legally classified as pre-marketing, which triggers specific notification requirements. Specifically:
- The AIFM must notify its home competent authority within two weeks of beginning pre-marketing
- The notification must specify the member states and periods in which pre-marketing is or has taken place
- Only professional investors (as defined under MiFID II Annex II) can be engaged in pre-marketing
- Pre-marketing materials cannot contain subscription documents or final fund terms
"Most GPs treat an NDA and a deck as informal. Under CBDF, that conversation is already regulated." — Balentic compliance notes, 2025
AIFMD II: the updated passport regime
AIFMD II, which entered into force in April 2024, introduced several changes relevant to GP fundraising compliance in Europe. The key updates include:
Delegation and substance requirements
AIFMD II tightened requirements on AIFM delegation arrangements, requiring that AIFMs maintain sufficient substance in their home jurisdiction. For fund managers using third-party AIFMs or "letter-box" structures, this creates additional risk that was not present under the original AIFMD framework.
Loan origination fund rules
Private credit GPs now face specific rules under AIFMD II for loan-originating AIFs, including concentration limits, risk retention requirements, and restrictions on leveraged lending. This affects compliance for a growing segment of European GPs active in the private credit space.
ESG disclosure alignment
AIFMD II aligned with SFDR Regulation (EU) 2019/2088, requiring AIFMs to disclose how sustainability risks are integrated into investment decisions at both entity and product level. LPs are increasingly requiring SFDR classification (Article 6, 8, or 9) before engaging in due diligence, making this a practical fundraising requirement, not just a regulatory one.
National private placement regimes: the compliance map
Outside the EU, and for non-EU AIFMs marketing into the EU, national private placement regimes (NPPRs) remain the primary route to compliance. The practical challenge is that NPPRs vary significantly across jurisdictions:
- Germany: BaFin registration required; Investor Information Document in German; specific reporting requirements under the Kapitalanlagegesetzbuch (KAGB)
- France: AMF pre-approval for NPPR marketing; rigorous disclosure requirements; no passive marketing exceptions
- Nordic markets (Sweden, Denmark, Norway): Generally more permissive regimes for professional investors, but each requires separate notification; reverse solicitation claims are closely scrutinized
- Netherlands: AFM notification required; relatively straightforward for professional investors; exemptions for sovereign wealth and certain pension investors
What compliance-aware fundraising looks like in practice
The GPs who navigate European compliance most effectively have operationalized compliance into their fundraising workflow, rather than treating it as a legal checkpoint at the end. Compliance-aware fundraising has four components:
- LP categorization at first contact. Verify professional investor status before any substantive materials are shared. This means having a documented process for MiFID II professional investor assessment, not just checking a box on an NDA.
- Engagement logging. Every material communication with a prospective LP should be logged with date, content summary, and recipient status. This creates the audit trail required under AIFMD and MiFID II in the event of an inquiry.
- Jurisdiction mapping. Before beginning outreach in any new EU jurisdiction, the fund manager should have a clear view of whether they are operating under the AIFMD passport, a national NPPR, or a reverse solicitation exemption — and document that assessment.
- Pre-marketing notifications. Build the CBDF pre-marketing notification process into the fundraising timeline as a default, not a reactive step. Most GPs underestimate the lead time required for home authority notifications.
How Orca's compliance infrastructure supports European GPs
Orca is built with European GP fundraising compliance requirements embedded in the platform design. LP profiles are verified professional investor status. Engagement logs are automatically maintained. Pre-marketing workflows are structured to align with CBDF notification requirements.
For a GP running a cross-border European fundraise, the compliance burden is reduced because the discovery and engagement infrastructure is already compliant by design — rather than requiring retrofit compliance on top of a general-purpose CRM.
If you're a GP fundraising in Europe in 2026 and your compliance workflow doesn't include CBDF pre-marketing notifications, a jurisdiction-by-jurisdiction NPPR map, and engagement logging at every touchpoint — the risk isn't abstract. It's the next close that doesn't complete.